Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 485132, 6 pages
http://dx.doi.org/10.1155/2015/485132
Research Article

The Genetic Profile from HLA and Non-HLA Loci Allows Identification of Atypical Type 2 Diabetes Patients

1Biodiversity and Genetic Department, Instituto de Investigaciones Biológicas Clemente Estable, 11600 Montevideo, Uruguay
2Teaching Care Unit, Unit of Diabetes “Hospital Pasteur”, ASSE, Ministry of Public Health, 11600 Montevideo, Uruguay
3Diabetology Service of “Centro de Asistencia del Sindicato Médico del Uruguay”, 11800 Montevideo, Uruguay

Received 29 January 2015; Accepted 23 March 2015

Academic Editor: Joseph Fomusi Ndisang

Copyright © 2015 Matias Fabregat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. INE (Instituto Nacional de Estadística), 2011, http://www.ine.gub.uy/censos2011/index.html.
  2. M. Sans, G. Figueiro, and P. C. Hidalgo, “A new mitochondrial C1 lineage from the prehistory of Uruguay: population genocide, ethnocide, and continuity,” Human Biology, vol. 84, no. 3, pp. 287–305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Ferrero and T. Garcia, “Survey on the prevalence of diabetes in Uruguay,” Archives of Internal Medicine, vol. 27, pp. 1–12, 2005. View at Google Scholar
  4. A. Mimbacas, L. García, P. Zorrilla et al., “Genotype and phenotype correlations in diabetic patients in Uruguay,” Genetics and Molecular Research, vol. 8, no. 4, pp. 1352–1358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mimbacas and G. Javiel, “Diabetes type 1 and type 2: what is behind a classification?” in Type 1 Diabetes. Complications, Pathogenesis, and Alternative Treatments, C.-P. Liu, Ed., pp. 287–304, InTech, 2011. View at Google Scholar
  6. A. Mimbacas, G. Vitarella, J. Souto et al., “The phenotype masks the genotype: a possible new expression of diabetes,” Journal of Pediatric Genetics, vol. 1, no. 2, pp. 131–134, 2012. View at Publisher · View at Google Scholar
  7. American Diabetes Association. Position Statement, “Standards of medical care in diabetes,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2012. View at Publisher · View at Google Scholar
  8. I. M. Libman and D. J. Becker, “Coexistence of type 1 and type 2 diabetes mellitus: ‘double’ diabetes?” Pediatric Diabetes, vol. 4, no. 2, pp. 110–113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kolb and T. Mandrup-Poulsen, “An immune origin of type 2 diabetes?” Diabetologia, vol. 48, no. 6, pp. 1038–1050, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Tuomi, “Type 1 and type 2 diabetes: what do they have in common?” Diabetes, vol. 54, supplement 2, pp. S40–S45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Pozzilli and R. Buzzetti, “A new expression of diabetes: double diabetes,” Trends in Endocrinology & Metabolism, vol. 18, no. 2, pp. 52–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Pozzilli, C. Guglielmi, E. Pronina, and E. Petraikina, “Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths,” Pediatric Diabetes, vol. 8, no. 9, pp. 88–95, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Stone, J. Camosso-Stefinovic, J. Wilkinson, S. de Lusignan, A. T. Hattersley, and K. Khunti, “Incorrect and incomplete coding and classification of diabetes: a systematic review,” Diabetic Medicine, vol. 27, no. 5, pp. 491–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Inzucchi, R. M. Bergenstal, J. B. Buse et al., “Management of hyperglycemia in type2 diabetes: a patient-centered approach,” Diabetes Care, vol. 35, pp. 1364–1379, 2012. View at Google Scholar
  15. M. Fernández, M. Fabregat, G. Javiel, and A. Mimbacas, “HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients,” World Journal of Diabetes, vol. 5, no. 5, pp. 711–716, 2014. View at Publisher · View at Google Scholar
  16. N. M. Maruthur, M. O. Gribble, W. L. Bennett et al., “The pharmacogenetics of type 2 Diabetes: a systematic review,” Diabetes Care, vol. 37, no. 3, pp. 876–886, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Gascue, Análisis de polimorfismos de riesgo a la diabetes tipo 1 en una población trihíbrida, Uruguay Montevideo, Uruguay [M.S. thesis], LAP LAMBERT Academic Publishing GmbH & Company KG, 2007, http://www.bod.de/shop/buch.html?&bookId=587987.
  18. M. I. McCarthy and P. Froguel, “Genetic approaches to the molecular understanding of type 2 diabetes,” American Journal of Physiology - Endocrinology and Metabolism, vol. 283, no. 2, pp. E217–E225, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. S. T. Bennett and J. A. Todd, “Human type 1 diabetes and the insulin gene: principles of mapping polygenes,” Annual Review of Genetics, vol. 30, pp. 343–370, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. G. I. Bell, M. J. Selby, and W. J. Rutter, “The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences,” Nature, vol. 295, no. 5844, pp. 31–35, 1982. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Cimponeriu, P. Apostol, I. Radu et al., “The insulin polymorphism -23Hph increases the risk for type 1 diabetes mellitus in the Romanian population,” Genetics and Molecular Biology, vol. 33, no. 4, pp. 610–614, 2010. View at Publisher · View at Google Scholar
  22. S. T. Bennett, A. M. Lucassen, S. C. L. Gough et al., “Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus,” Nature Genetics, vol. 9, no. 3, pp. 284–292, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. S. T. Bennett, A. J. Wilson, F. Cucca et al., “IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus,” Journal of Autoimmunity, vol. 9, no. 3, pp. 415–421, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Pugliese, Z. L. Awdeh, C. A. Alper, R. A. Jackson, and G. S. Eisenbarth, “The INS B allele (1,428 Fok I) is associated with reduced IDDM incidence in autoantibody-positive first degree relatives despite the presence of autoantibodies and high-risk HLA alleles,” Transplantation Proceedings, vol. 27, no. 6, p. 3392, 1995. View at Google Scholar · View at Scopus
  25. A. M. Lucassen, G. R. Screaton, C. Julier, T. J. Elliott, M. Lathrop, and J. I. Bell, “Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype,” Human Molecular Genetics, vol. 4, no. 4, pp. 501–506, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. H. Stead and A. J. Jeffreys, “Allele diversity and germline mutation at the insulin minisatellite,” Human Molecular Genetics, vol. 9, no. 5, pp. 713–723, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Cejkova, P. Novota, M. Cerna et al., “HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients,” International Journal of Immunogenetics, vol. 35, no. 2, pp. 133–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Julier, A. Lucassen, P. Villedieu et al., “Multiple DNA variant association analysis: application to the insulin gene region in type I diabetes,” The American Journal of Human Genetics, vol. 55, no. 6, pp. 1247–1254, 1994. View at Google Scholar · View at Scopus
  29. Asociación Latinoamericana de Diabetes (ALAD), 2012 Guias ALAD de diagnóstico, control y tratamiento de la diabetes tipo 2, http://alad-latinoamerica.org/.
  30. A. Mimbacas, F. Perez-Bravo, P. C. Hidalgo et al., “Association between diabetes type 1 and DQB1 alleles in a case-control study conducted in Montevideo, Uruguay,” Genetics and Molecular Research, vol. 2, pp. 29–35, 2003. View at Google Scholar
  31. D. M. Nathan, J. B. Buse, M. B. Davidson et al., “Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy,” Diabetes Care, vol. 32, no. 1, pp. 193–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. World Health Organization, “BMI classification,” http://www.who.int/gho/ncd/risk_factors/bmi_text/en/.
  33. P. Zorrilla, Polimorfismos asociados a Diabetes Mellitus Tipo 1 en el gen PTPN22 en la población de Montevideo, Editorial Academica Espanola, 2011, https://www.eae-publishing.com/catalog/search.
  34. W. Fendler, K. Wyka, A. Cieślik-Heinrich, E. Polakowska, J. Jastrzebska, and W. Młynarski, “The 5′VNTR proinsulin gene (INS) polymorphism and the functional reserve of β cells in the intravenous glucose tolerance test,” Pediatric Endocrinology, Diabetes and Metabolism, vol. 17, no. 1, pp. 5–9, 2011. View at Google Scholar · View at Scopus